Diagnostic Value of High-risk HPV Other Than Type 16/18 in High-grade Cervical Neoplasia Among Cytology-negative Women: A Multicenter Retrospective Study

Overview

Journal Cancer Med

Specialty Oncology

Date 2023 May 18

PMID 37199394

Authors

Anying Bai

Peng Xue

Qing Li

Yu Jiang

Youlin Qiao

Affiliations

Soon will be listed here.

Abstract

Background: Human papillomavirus (HPV) is a necessary cause of cervical cancer, and a tool more sensitive than cytology for the early screening of cervical precancers. The two most carcinogenic genotypes HPV 16/18 have been reported in the majority of studies. High-risk HPVs other than HPV 16/18 (non-16/18-hrHPVs) cause approximately a quarter of cervical cancers, and we aimed to analyze the genotype-specific prevalence, risk and diagnostic efficiency of non-16/18-hrHPVs in cervical carcinogenesis among Chinese cytology-negative women.

Methods: A total of 7043 females who had abnormal cervical testing results from January 2018 to October 2021 were enrolled, among them 3091 were cytology-negative. Descriptive statistics was used to estimate the HPV genotype-specific prevalence, and multivariable logistic regression was used to estimate the genotype-specific non-16/18 hrHPVs risk of cervical carcinogenesis. The evaluation of diagnostic value among HPV genotypes included the possibility of predicting cervical intraepithelial neoplasia grade 2/3 or worse (CIN2+/CIN3+) and the diagnostic efficiency measured by increased referral rate and referral numbers of colposcopies per additional CIN2+/CIN3+ detected.

Results: Among HPV-positive cytology-negative women, the five dominant genotypes for CIN2+/CIN3+ were HPV 31/33/35/52/58. HPV 52/58/33 had comparatively high sensitivity and specificity in predicting CIN2+/CIN3+, while the referral strategy of multiple HPV58 required 26 colposcopies to detect 1 CIN3+, compared with 14, 12, and 8 required by multiple HPV52, 31, and 33, respectively.

Conclusions: HPV31/33/35/52/58 infections are significant risk factors for cervical lesions, and multiple HPV 31/33/52 infections should be included in the previously recommended HPV16/18 genotyping triage for colposcopy in China, as the benefits of disease prevention may outweigh the disadvantages of increasing requirements for colposcopy services.

Citing Articles

Retrospective Analysis of Human Papillomavirus Genotyping and Cytology (Pap Smears) in Cervical Cancer Screening: An Institutional Experience in the State of Oregon, USA.

Lu Z, Knapp M, Downs S, Ali R, Morgan T, Ruff H Diagnostics (Basel). 2025; 15(4).

PMID: 40002570 PMC: 11854604. DOI: 10.3390/diagnostics15040419.

Decoding impact of human papillomavirus in gynecological oncology: a narrative review.

Sarker M, Pervez M Obstet Gynecol Sci. 2025; 68(1):30-42.

PMID: 39780583 PMC: 11788691. DOI: 10.5468/ogs.24226.

Performance of visual inspection, partial genotyping, and their combination for the triage of women living with HIV who are screen positive for human papillomavirus: Results from the AIMA-CC ANRS 12375 multicentric screening study.

Debeaudrap P, Kabore F, Setha L, Tegbe J, Doukoure B, Sotheara M Int J Cancer. 2024; 156(3):598-607.

PMID: 39319557 PMC: 11621995. DOI: 10.1002/ijc.35190.

HPV specificity and multiple infections and association with cervical cytology in Chongqing, China: a cross-sectional study.

Luo Q, Zhang H, Zeng X, Han N, Ma Z, Luo H BMC Infect Dis. 2024; 24(1):804.

PMID: 39123121 PMC: 11313099. DOI: 10.1186/s12879-024-09693-3.

Immediate risk of cervical intraepithelial neoplasia and diagnostic value of colposcopy among cytology-negative women with oncogenic HPV: a retrospective study.

Dai W, Wang T, Chen L, Qiu Z, Chen P, Chen D BMC Womens Health. 2024; 24(1):419.

PMID: 39049047 PMC: 11267838. DOI: 10.1186/s12905-024-03258-x.

References

Kjaer S, Frederiksen K, Munk C, Iftner T . Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010; 102(19):1478-88. PMC: 2950170. DOI: 10.1093/jnci/djq356. View

Bai A, Xue P, Li Q, Jiang Y, Qiao Y . Diagnostic value of high-risk HPV other than type 16/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study. Cancer Med. 2023; 12(13):14794-14805. PMC: 10358197. DOI: 10.1002/cam4.6109. View

Perkins R, Guido R, Castle P, Chelmow D, Einstein M, Garcia F . 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020; 24(2):102-131. PMC: 7147428. DOI: 10.1097/LGT.0000000000000525. View

Zhong F, Yu T, Ma X, Wang S, Cong Q, Tao X . Extensive HPV Genotyping Reveals High Association between Multiple Infections and Cervical Lesions in Chinese Women. Dis Markers. 2022; 2022:8130373. PMC: 9205720. DOI: 10.1155/2022/8130373. View

Chen W, Zhang X, Molijn A, Jenkins D, Shi J, Quint W . Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes Control. 2009; 20(9):1705-13. DOI: 10.1007/s10552-009-9422-z. View

Hoste G, Vossaert K, Poppe W . The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening. Obstet Gynecol Int. 2013; 2013:610373. PMC: 3713364. DOI: 10.1155/2013/610373. View

Bosgraaf R, Siebers A, de Hullu J, Massuger L, Bulten J, Bekkers R . The current position and the future perspectives of cervical cancer screening. Expert Rev Anticancer Ther. 2013; 14(1):75-92. DOI: 10.1586/14737140.2014.856273. View

Wentzensen N, Nason M, Schiffman M, Dodd L, Hunt W, Wheeler C . No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study. J Infect Dis. 2013; 209(6):855-64. PMC: 3935473. DOI: 10.1093/infdis/jit577. View

Liu Y, Liao J, Yi X, Pan Z, Pan J, Sun C . Diagnostic value of colposcopy in patients with cytology-negative and HR-HPV-positive cervical lesions. Arch Gynecol Obstet. 2022; 306(4):1161-1169. DOI: 10.1007/s00404-022-06415-5. View

10.

Cuschieri K, Ronco G, Lorincz A, Smith L, Ogilvie G, Mirabello L . Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs. Int J Cancer. 2018; 143(4):735-745. DOI: 10.1002/ijc.31261. View

11.

Behtash N, Mehrdad N . Cervical cancer: screening and prevention. Asian Pac J Cancer Prev. 2007; 7(4):683-6. View

12.

Hashim D, Engesaeter B, Skare G, Castle P, Bjorge T, Trope A . Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening. Br J Cancer. 2020; 122(11):1715-1723. PMC: 7250848. DOI: 10.1038/s41416-020-0790-1. View

13.

Wu P, Xiong H, Yang M, Li L, Wu P, Lazare C . Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study. Gynecol Oncol. 2019; 155(3):436-443. DOI: 10.1016/j.ygyno.2019.10.003. View

14.

Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett T, Cheung L, Chen X . A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. EClinicalMedicine. 2020; 22:100293. PMC: 7264956. DOI: 10.1016/j.eclinm.2020.100293. View

15.

Saslow D, Solomon D, Lawson H, Killackey M, Kulasingam S, Cain J . American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012; 62(3):147-72. PMC: 3801360. DOI: 10.3322/caac.21139. View

16.

Adcock R, Cuzick J, Hunt W, McDonald R, Wheeler C . Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia. Cancer Epidemiol Biomarkers Prev. 2019; 28(11):1816-1824. PMC: 8394698. DOI: 10.1158/1055-9965.EPI-19-0239. View

17.

Zhang J, Zhang D, Yang Z, Wang X, Wang D . The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China. BMC Cancer. 2020; 20(1):443. PMC: 7236298. DOI: 10.1186/s12885-020-06935-w. View

18.

Cuzick J, Wheeler C . Need for expanded HPV genotyping for cervical screening. Papillomavirus Res. 2017; 2:112-115. PMC: 5886893. DOI: 10.1016/j.pvr.2016.05.004. View

19.

Zhang B, Hong S, Zhang G, Rong F . Clinical application of the 2011 IFCPC colposcope terminology. BMC Womens Health. 2021; 21(1):257. PMC: 8223298. DOI: 10.1186/s12905-021-01395-1. View

20.

Li M, Du X, Lu M, Zhang W, Sun Z, Li L . Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China. J Med Virol. 2018; 91(3):473-481. DOI: 10.1002/jmv.25331. View